Health

American Indian and Alaska Native infants experience the highest rates of RSV-related hospitalization in the U.S., but a breakthrough immunization is helping to close the gap

RSV is the leading cause of infant hospitalizations in the U.S. But that could soon change as research advances lead to new preventive drugs for everyone

Tragic RSV vaccine trials in the 1960s set the field back for decades. Here’s how scientists finally made breakthroughs in RSV immunization

Abigail Echo-Hawk, a preeminent Native American public health expert, discusses RSV, “data genocide” and positive change driven by Indigenous storytelling

The year 2023 marked the debut of groundbreaking innovations to prevent severe RSV infections in infants. Now protected babies are way less likely to develop severe infections or to end up in the ICU

Respiratory syncytial virus (RSV) continues to affect infants and older and immunocompromised people around the world. These graphics reveal where the burden lies and what the effects of immunizations are

The common pain reliever is safe when used as directed, research shows. But scientists remain puzzled by one aspect: how it reduces pain and fever

President Trump and Robert F. Kennedy, Jr., have tied Tylenol use during pregnancy and folate deficiencies to rising autism rates—but the evidence is thin

A revamped CDC advisory committee faces vaccine debates, studies reveal brain changes in athletes, and climate change drives deadly heat waves across Europe.

Winners of the annual Ig Nobel awards include the science of tipsy bats and the physics of cacio e pepe

A large language model called Delphi-2M analyzes a person’s medical records and lifestyle to provide risk estimates for more than 1,000 diseases

Three vaccines were on the agenda for this week’s meeting of ACIP, the CDC’s key advisory panel on immunization: the combined measles, mumps, rubella and varicella vaccine, the hepatitis B vaccine and COVID vaccines